Valuation: Chugai Pharmaceutical Co., Ltd.

Market Cap 11,75700Cr 7.36TCr 6.64TCr 6.13TCr 5.55TCr 10TCr 6,89000Cr 11TCr 73TCr 29TCr 3,70500Cr 28TCr 27TCr P/E 2026 *
23.1x
P/E 2027 * 20.3x
Enterprise Value 10,84100Cr 6.78TCr 6.12TCr 5.65TCr 5.12TCr 9.67TCr 6,35300Cr 9.92TCr 67TCr 27TCr 3,41600Cr 25TCr 25TCr EV / Sales 2026 *
7.77x
EV / Sales 2027 * 6.94x
Free-Float
38.12%
Yield 2026 *
1.89%
Yield 2027 * 2.13%
1 day-0.22%
1 week+4.43%
Current month+4.75%
1 month+18.72%
3 months+0.48%
6 months-9.54%
Current year-13.31%
1 week 6,700
Extreme 6700
7,381
1 month 6,036
Extreme 6036
7,381
Current year 5,974
Extreme 5974
10,700
1 year 5,974
Extreme 5974
10,700
3 years 4,572
Extreme 4572
10,700
5 years 3,191
Extreme 3191
10,700
10 years 1,003.33
Extreme 1003.333333
10,700
Manager TitleAgeSince
Chief Executive Officer 63 01/03/2021
Director of Finance/CFO 59 28/03/2024
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 63 01/03/2020
Director/Board Member 59 28/03/2024
Director/Board Member 51 01/03/2025
Change 5-day change 1-year change 3-year change Capi.($)
-0.22%+4.43%-1.27%+52.76% 7.42TCr
+0.35%+1.98%+48.69%+140.47% 1,27600Cr
-0.13%+5.35%+48.83%+90.43% 68TCr
+0.37%+3.14%+34.87%+112.84% 52TCr
+0.02%+2.79%+44.10%+69.76% 39TCr
-0.59%+1.73%+69.66%+45.16% 36TCr
-1.29%+0.94%+29.88%+58.29% 31TCr
+0.09%+0.99%+5.87%+37.72% 29TCr
+0.62%+1.49%+44.63%+75.12% 25TCr
-0.67%+1.35%+43.66%+123.56% 21TCr
Average -0.09%+2.57%+36.89%+80.61% 44TCr
Weighted average by Cap. +0.08%+2.55%+42.93%+96.47%

Financials

2026 *2027 *
Net sales 1,39600Cr 873.34Cr 787.93Cr 727.51Cr 658.56Cr 1.24TCr 82TCr 1.28TCr 8.64TCr 3.47TCr 44TCr 3.28TCr 3.21TCr 1,52700Cr 955.72Cr 862.25Cr 796.13Cr 720.68Cr 1.36TCr 89TCr 1.4TCr 9.45TCr 3.8TCr 48TCr 3.59TCr 3.51TCr
Net income 51TCr 318.98Cr 287.79Cr 265.72Cr 240.54Cr 454.72Cr 30TCr 466.45Cr 3.16TCr 1.27TCr 16TCr 1.2TCr 1.17TCr 58TCr 361.75Cr 326.38Cr 301.35Cr 272.79Cr 515.69Cr 34TCr 528.99Cr 3.58TCr 1.44TCr 18TCr 1.36TCr 1.33TCr
Net Debt -92TCr -573.51Cr -517.43Cr -477.74Cr -432.47Cr -817.56Cr -54TCr -838.64Cr -5.67TCr -2.28TCr -29TCr -2.15TCr -2.11TCr -1,16400Cr -728.42Cr -657.19Cr -606.79Cr -549.28Cr -1.04TCr -68TCr -1.07TCr -7.21TCr -2.89TCr -37TCr -2.73TCr -2.68TCr
Projected Income Statement - Annual - Chugai Pharmaceutical Co., Ltd.
Logo Chugai Pharmaceutical Co., Ltd.
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALECENSA, Kadcyla, GAZYVA, CellCept, Zelboraf, Xeloda, Tamiflu, Tarceva, Tecentriq, Herceptin, Perjeta, cancer gene panel testing and others. These products are primarily used to treat conditions such as cancer, kidney disease and kidney transplantation, bone and joint diseases (rheumatoid arthritis), neurological and muscular diseases (neuromyelitis optica spectrum disorders, spinal muscular atrophy, and Duchenne muscular dystrophy), blood disorders (hemophilia and paroxysmal nocturnal hemoglobinuria), and eye diseases (retinal disorders). It also engages in administrative operations, the provision of scientific information on pharmaceuticals, investment activities, and the provision of influenza information services.
Employees
5,104
Date Price Change Volume
11/26/11 JP¥7,146.00 -0.22% 30,42,200
10/26/10 JP¥7,162.00 -0.32% 24,55,900
09/26/09 JP¥7,185.00 +5.57% 31,39,300
06/26/06 JP¥6,806.00 -5.34% 52,46,700
05/26/05 JP¥7,190.00 +4.28% 47,37,600
Trader
Investor
Global
Quality
ESG MSCI
AA
MarketScreener Ratings - Chugai Pharmaceutical Co., Ltd.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
15
Last Close Price
7,146.00JPY
Average target price
8,393.33JPY
Spread / Average Target
+17.45%
  1. Stock Market
  2. Stocks
  3. 4519 Stock